简体中文 | 繁體中文 | English

Products & Services News

2019-12-12 16:29 Seattle Genetics and Takeda Announce Additional Analyses of ADCETRIS® (Brentuximab Vedotin) ECHELON-1 and ECHELON-2 Phase 3 Clinical Trials at the 2019 ASH Annual Meeting
2019-12-12 15:08 Lattice Announces New Low Power FPGA Platform
2019-12-12 14:14 Hydrogène de France Announces the World's First Plant for Mass Production of High-Powered Fuel Cells (Over 1 MW)
2019-12-12 14:09 Lattice Accelerates FPGA Design with New Lattice Radiant 2.0 Design Software
2019-12-12 12:01 PLDA Announces Augmented Presence in Asia With Increased R&D, Support and Sales, and a New Chinese Language Website
2019-12-12 11:56 PCI Pharma Services Announces Major Investment to Expand Development and Manufacturing Capabilities at Tredegar, UK Site
2019-12-12 10:06 Toshiba Launches General-Purpose System Power IC with Multiple Outputs for Automotive Functional Safety
2019-12-12 09:58 New Charter Seeks to Build Global Support for Tolerance and Religious Freedom
2019-12-12 09:47 Nel ASA: Receives Purchase Order for a 3.5 MW Electrolyser from ENGIE
2019-12-12 09:44 PTW International Announces Orange Rock Studios, Their Product and Game Development Arm
2019-12-12 09:40 P.I. Works Expands Presence in the North America and Latin America
2019-12-11 18:56 Visa and Global Partners Expand Access to Cross-Border Payments for Consumers and SMBs
2019-12-11 18:54 redONE Choose MDS Global's VNOnDemand BSS-as-a-Service To Support Accelerating Regional Expansion
2019-12-11 16:40 Saga Announces the Official Launch of the SGA Token
2019-12-11 16:37 GSMA Announces First Details for MWC Shanghai 2020
2019-12-11 16:34 ExaGrid and Veeam Meet Emerging Backup Requirements for Enterprise Data Centers
2019-12-11 16:29 Post Malone and Crocs Launch Fourth Collaboration
2019-12-11 16:05 Takeda Demonstrates Its Long-Standing Commitment to Advancing Treatments for Rare Bleeding Disorders with Studies Highlighting Real-World Evidence and Investigational Gene Therapy at ASH 2019
2019-12-11 14:45 GA-ASI Begins Demonstration Flights in Greece
2019-12-11 11:15 Takeda to Present Results from the Phase 3 TOURMALINE-AL1 Trial of NINLARO in Patients with Amyloidosis

Business Wire Weibo

Press Releases

Latest Releases